Eagle Football Group Société anonyme (EFG.PA)
EUR 1.97
(-0.51%)
EUR 1.97
(-0.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -113.18 Million | -53.95 Million | -16.07 Million | -43.38 Million |
| Net Income | -98.97 Million | -55.01 Million | -107.46 Million | -36.6 Million |
| Depreciation & Amortization | 61.58 Million | 65.72 Million | 21.31 Million | 76.24 Million |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | -15.67 Million | -22.4 Million | 45.12 Million | -12.5 Million |
| Other non-cash items | 16.74 Million | 13.52 Million | 70.53 Million | 14.06 Million |
| Investing Cash Flow | 52.09 Million | 5.94 Million | -34.62 Million | 81.93 Million |
| Investments in PPE | -56.78 Million | -68.62 Million | -84.91 Million | -66.91 Million |
| Acquisitions | - | - | - | -1.11 Million |
| Investment purchases | -444 Thousand | -41.64 Million | -1.44 Million | -4.31 Million |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | 61.78 Million | - | - | 4.25 Million |
| Financing Cash Flow | 68.43 Million | 6.05 Million | 87.39 Million | -17.6 Million |
| Debt repayment | -20.41 Million | -8.68 Million | -105.58 Million | -5.33 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | -338 Thousand | -2.09 Million | -1.75 Million |
| Common Stock Issuance | 83.35 Million | - | - | - |
| Other Financing Activities | 20.99 Million | 10.5 Million | - | - |
| Accounts receivables | 9.05 Million | - | - | - |
| Accounts payables | - | - | - | - |
| Inventory | -615 Thousand | 526 Thousand | 157 Thousand | -559 Thousand |
| Other working capital | -24.11 Million | - | - | - |
| Cash at beginning of period | 27.29 Million | 69.24 Million | 32.54 Million | 11.6 Million |
| Cash at end of period | 34.63 Million | 27.29 Million | 69.24 Million | 32.54 Million |
| Capital Expenditure | -56.78 Million | -68.62 Million | -84.91 Million | -66.91 Million |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 7.34 Million | -41.95 Million | 36.69 Million | 20.94 Million |
| Free Cash Flow | -169.96 Million | -122.58 Million | -100.98 Million | -110.29 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -30.31 Million | -30.31 Million | -18.81 Million | -98.97 Million | -18.81 Million | -30.09 Million |
| Depreciation & Amortization | 14.26 Million | 14.26 Million | 17.98 Million | 61.58 Million | 17.98 Million | 13.03 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 7.34 Million | 7.34 Million | -15.29 Million | -15.67 Million | -15.29 Million | 12.41 Million |
| Other non-cash items | -67 Thousand | -67 Thousand | -14.93 Million | 16.74 Million | -14.93 Million | -20.89 Million |
| Investing Cash Flow | 4.32 Million | 4.32 Million | 36.89 Million | 52.09 Million | 36.89 Million | -10.85 Million |
| Investments in PPE | -2.3 Million | -2.3 Million | -2.9 Million | -56.78 Million | -2.9 Million | -1.71 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -444 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 6.62 Million | 6.62 Million | 39.8 Million | - | 39.8 Million | -9.13 Million |
| Financing Cash Flow | 10.96 Million | 10.96 Million | 2.45 Million | 68.43 Million | 2.45 Million | 31.76 Million |
| Debt repayment | - | - | - | -20.41 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -7.24 Million | -7.24 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | 83.35 Million | - | - |
| Other Financing Activities | 18.21 Million | 18.21 Million | 2.45 Million | 20.99 Million | 2.45 Million | 31.76 Million |
| Accounts receivables | 7.34 Million | 7.34 Million | -15.29 Million | - | -15.29 Million | 12.41 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | -615 Thousand | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | 27.29 Million | 18.04 Million | 22.66 Million |
| Cash at end of period | 6.51 Million | 6.51 Million | 8.29 Million | 34.63 Million | 26.33 Million | 18.04 Million |
| Capital Expenditure | -2.3 Million | -2.3 Million | -2.9 Million | -56.78 Million | -2.9 Million | -1.71 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 6.51 Million | 6.51 Million | 8.29 Million | 7.34 Million | 8.29 Million | -4.62 Million |
| Free Cash Flow | -11.07 Million | -11.07 Million | -33.96 Million | -169.96 Million | -33.96 Million | -27.24 Million |
AVA
IVSXF
6113
AJANTPHARM
7472
NSIT